Health Update: New Non-Invasive Test for Colorectal Cancer

There will be more than 130,000 new cases of colorectal cancer this year - a leading cause of cancer death in our country. The good news is that it has a high survival rate if diagnosed early.

One of the best ways to reduce our risk of colorectal cancer is to detect polyps, which can lead to the disease.  Now a new, non-invasive urine based test can help us do just that.

Atlantic Diagnostic Laboratories recently announced the official launch of PolypDx™, a non-invasive urine-based diagnostic test for detection of adenomatous polyps, the precursor to colorectal cancer. Once screened, patients who are at risk for polyps can be directed to a colonoscopy, during which the polyps can be completely and safely removed, preventing the progression to colorectal cancer.  PolypDx™ is a simple and effective test requiring only a small urine sample.

“ADL, with its extensive expertise, is very excited to be offering the PolypDx™ non-invasive urine test for its official launch into America,” said Aaron Domenico, Chief Operating Officer of ADL. “Colorectal cancer is a leading cause of death in the United States.  With early detection in the adenomatous polyp stage, this form of cancer is preventable.”  ADL has several laboratories, including one in Egg Harbor Township. A prescription from a medical professional is required to get the screening.